Characteristics of study volunteers
Clinical variable | Control volunteers | UC |
---|---|---|
Age (mean, range) | 37.5 (21–55) | 39.5 (23–58) |
Gender (M/F) | 2/2 | 3/2 |
Clinical indication | Microcytic anaemia (2/4) | Medically-refractory UC (5/5) |
Change in bowel habit (1/4) | ||
Abdominal pain (1/4) | ||
Endoscopic findings | Normal | NA |
Histological findings | No inflammation | (See table 2) |
Medications (number/total) | L-thyroxine (1/4) | Calcium/vitamin D (4/5) |
Pantoprazole (2/5) | ||
Contraceptive pill (1/4) | Fluoxetine (1/5) | |
Immunosuppression (number/total) | None | Corticosteroids (5/5) |
Aminosalicylates (3/5) | ||
Mercaptopurines (4/5) | ||
Infliximab (3/5) | ||
Adalimumab (1/5) |